Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where P. Darwin Bell is active.

Publication


Featured researches published by P. Darwin Bell.


The New England Journal of Medicine | 2015

Fibrosis — A Common Pathway to Organ Injury and Failure

Don C. Rockey; P. Darwin Bell; Joseph A. Hill

Fibrosis is a consequence of the inflammatory response. When fibrotic tissue becomes excessive, it can have diverse pathophysiological effects on a number of organ systems. The mechanisms underlying fibrosis and approaches to therapy are reviewed.


Journal of The American Society of Nephrology | 2011

Loss of Primary Cilia Upregulates Renal Hypertrophic Signaling and Promotes Cystogenesis

P. Darwin Bell; Wayne R. Fitzgibbon; Kelli M. Sas; Antine E. Stenbit; May Y. Amria; Amber Houston; Ryan Reichert; Sandra K. Gilley; Gene P. Siegal; John J. Bissler; Mehmet Bilgen; Peter Cheng Te Chou; Lisa M. Guay-Woodford; Brad Yoder; Courtney J. Haycraft; Brian J. Siroky

Primary cilia dysfunction alters renal tubular cell proliferation and differentiation and associates with accelerated cyst formation in polycystic kidney disease. However, the mechanism leading from primary ciliary dysfunction to renal cyst formation is unknown. We hypothesize that primary cilia prevent renal cyst formation by suppressing pathologic tubular cell hypertrophy and proliferation. Unilateral nephrectomy initiates tubular cell hypertrophy and proliferation in the contralateral kidney and provides a tool to examine primary cilia regulation of renal hypertrophy. Conditional knockout of the primary cilia ift88 gene leads to delayed, adult-onset renal cystic disease, which provides a window of opportunity to conduct unilateral nephrectomy and examine downstream kinetics of renal hypertrophy and cyst formation. In wild-type animals, unilateral nephrectomy activated the mTOR pathway and produced appropriate structural and functional hypertrophy without renal cyst formation. However, in ift88 conditional knockout animals, unilateral nephrectomy triggered increased renal hypertrophy and accelerated renal cyst formation, leading to renal dysfunction. mTOR signaling also increased compared with wild-type animals, suggesting a mechanistic cascade starting with primary ciliary dysfunction, leading to excessive mTOR signaling and renal hypertrophic signaling and culminating in cyst formation. These data suggest that events initiating hypertrophic signaling, such as structural or functional loss of renal mass, may accelerate progression of adult polycystic kidney disease toward end-stage renal disease.


PLOS Genetics | 2011

The exocyst protein Sec10 interacts with Polycystin-2 and knockdown causes PKD-phenotypes.

Ben Fogelgren; Shin-Yi Lin; Xiaofeng Zuo; Kimberly M. Jaffe; Kwon Moo Park; Ryan Reichert; P. Darwin Bell; Rebecca D. Burdine; Joshua H. Lipschutz

Autosomal dominant polycystic kidney disease (ADPKD) is characterized by formation of renal cysts that destroy the kidney. Mutations in PKD1 and PKD2, encoding polycystins-1 and -2, cause ADPKD. Polycystins are thought to function in primary cilia, but it is not well understood how these and other proteins are targeted to cilia. Here, we provide the first genetic and biochemical link between polycystins and the exocyst, a highly-conserved eight-protein membrane trafficking complex. We show that knockdown of exocyst component Sec10 yields cellular phenotypes associated with ADPKD, including loss of flow-generated calcium increases, hyperproliferation, and abnormal activation of MAPK. Sec10 knockdown in zebrafish phenocopies many aspects of polycystin-2 knockdown—including curly tail up, left-right patterning defects, glomerular expansion, and MAPK activation—suggesting that the exocyst is required for pkd2 function in vivo. We observe a synergistic genetic interaction between zebrafish sec10 and pkd2 for many of these cilia-related phenotypes. Importantly, we demonstrate a biochemical interaction between Sec10 and the ciliary proteins polycystin-2, IFT88, and IFT20 and co-localization of the exocyst and polycystin-2 at the primary cilium. Our work supports a model in which the exocyst is required for the ciliary localization of polycystin-2, thus allowing for polycystin-2 function in cellular processes.


Purinergic Signalling | 2009

ATP as a mediator of macula densa cell signalling

P. Darwin Bell; Peter Komlosi; Zhi-Ren Zhang

Within each nephro-vascular unit, the tubule returns to the vicinity of its own glomerulus. At this site, there are specialised tubular cells, the macula densa cells, which sense changes in tubular fluid composition and transmit information to the glomerular arterioles resulting in alterations in glomerular filtration rate and blood flow. Work over the last few years has characterised the mechanisms that lead to the detection of changes in luminal sodium chloride and osmolality by the macula densa cells. These cells are true “sensor cells” since intracellular ion concentrations and membrane potential reflect the level of luminal sodium chloride concentration. An unresolved question has been the nature of the signalling molecule(s) released by the macula densa cells. Currently, there is evidence that macula densa cells produce nitric oxide via neuronal nitric oxide synthase (nNOS) and prostaglandin E2 (PGE2) through cyclooxygenase 2 (COX 2)-microsomal prostaglandin E synthase (mPGES). However, both of these signalling molecules play a role in modulating or regulating the macula-tubuloglomerular feedback system. Direct macula densa signalling appears to involve the release of ATP across the basolateral membrane through a maxi-anion channel in response to an increase in luminal sodium chloride concentration. ATP that is released by macula densa cells may directly activate P2 receptors on adjacent mesangial cells and afferent arteriolar smooth muscle cells, or the ATP may be converted to adenosine. However, the critical step in signalling would appear to be the regulated release of ATP across the basolateral membrane of macula densa cells.


Apoptosis | 2012

A possible cross-talk between autophagy and apoptosis in generating an immune response in melanoma

Azim Hossain; Faisal F. Radwan; Bently P. Doonan; Jason M. God; Lixia Zhang; P. Darwin Bell; Azizul Haque

Melanoma is the most aggressive form of skin cancer, responsible for the majority of skin cancer related deaths. Thus, the search for natural molecules which can effectively destroy tumors while promoting immune activation is essential for designing novel therapies against metastatic melanoma. Here, we report for the first time that a natural triterpenoid, Ganoderic acid DM (GA-DM), induces an orchestrated autophagic and apoptotic cell death, as well as enhanced immunological responses via increased HLA class II presentation in melanoma cells. Annexin V staining and flow cytometry showed that GA-DM treatment induced apoptosis of melanoma cells, which was supported by a detection of increased Bax proteins, co-localization and elevation of Apaf-1 and cytochrome c, and a subsequent cleavage of caspases 9 and 3. Furthermore, GA-DM treatment initiated a possible cross-talk between autophagy and apoptosis as evidenced by increased levels of Beclin-1 and LC3 proteins, and their timely interplay with apoptotic and/or anti-apoptotic molecules in melanoma cells. Despite GA-DM’s moderate cytotoxicity, viable cells expressed high levels of HLA class II proteins with improved antigen presentation and CD4+ T cell recognition. The antitumor efficacy of GA-DM was also investigated in vivo in murine B16 melanoma model, where GA-DM treatment slowed tumor formation with a significant reduction in tumor volume. Taken together, these findings demonstrate the potential of GA-DM as a natural chemo-immunotherapeutic capable of inducing a possible cross-talk between autophagy and apoptosis, as well as improved immune recognition for sustained melanoma tumor clearance.


Cilia | 2013

An inducible CiliaGFP mouse model for in vivo visualization and analysis of cilia in live tissue

Amber K. O’Connor; Erik B. Malarkey; Nicolas F. Berbari; Mandy J. Croyle; Courtney J. Haycraft; P. Darwin Bell; Peter Hohenstein; Robert A. Kesterson; Bradley K. Yoder

BackgroundCilia are found on nearly every cell type in the mammalian body, and have been historically classified as either motile or immotile. Motile cilia are important for fluid and cellular movement; however, the roles of non-motile or primary cilia in most tissues remain unknown. Several genetic syndromes, called the ciliopathies, are associated with defects in cilia structure or function and have a wide range of clinical presentations. Much of what we know about the formation and maintenance of cilia comes from model systems like C. elegans and Chalmydomonas. Studies of mammalian cilia in live tissues have been hampered by difficulty visualizing them.ResultsTo facilitate analyses of mammalian cilia function we generated an inducible CiliaGFP mouse by targeting mouse cDNA encoding a cilia-localized protein somatostatin receptor 3 fused to GFP (Sstr3::GFP) into the ROSA26 locus. In this system, Sstr3::GFP is expressed from the ubiquitous ROSA26 promoter after Cre mediated deletion of an upstream Neo cassette flanked by lox P sites. Fluorescent cilia labeling was observed in a variety of live tissues and after fixation. Both cell-type specific and temporally regulated cilia labeling were obtained using multiple Cre lines. The analysis of renal cilia in anesthetized live mice demonstrates that cilia commonly lay nearly parallel to the apical surface of the tubule. In contrast, in more deeply anesthetized mice the cilia display a synchronized, repetitive oscillation that ceases upon death, suggesting a relationship to heart beat, blood pressure or glomerular filtration.ConclusionsThe ability to visualize cilia in live samples within the CiliaGFP mouse will greatly aid studies of ciliary function. This mouse will be useful for in vivo genetic and pharmacological screens to assess pathways regulating cilia motility, signaling, assembly, trafficking, resorption and length control and to study cilia regulated physiology in relation to ciliopathy phenotypes.


Comprehensive Physiology | 2011

The Renal Microcirculation

L. Gabriel Navar; William J. Arendshorst; Thomas L. Pallone; Edward W. Inscho; John D. Imig; P. Darwin Bell

Publisher Summary This chapter focuses on the renal microcirculation. The microcirculation of the kidney is particularly intriguing because optimum regulation of renal microcirculatory dynamics is essential for the appropriate control of the intracapillary and interstitial forces that determine glomerular filtration, reabsorption of salt and fluid from the renal interstitium back into the vascular compartment, and the regulation of the medullary concentration gradient. There continues to be intense interest on many aspects regarding the physiology of the renal microcirculation. This is largely attributable to the cardinal role of the kidneys in the regulation of body fluid volumes and sodium balance which influences the cardiovascular system and the regulation of arterial pressure. While it is certainly recognized that the sophisticated regulation of transport processes, subject to redundant and robust regulatory mechanisms in all the nephron segments, are ultimately responsible for regulating excretory function, these processes are dependent on optimal control of regional perfusion and interstitial forces within the kidney. There are intimate interactions between the microcirculation and tubular transport processes. The emerging data provides mounting evidence that many intrinsic and extrinsic signaling mechanisms and paracrine systems exert dual roles to regulate both vascular tone and epithelial transport function responsible for solute and water handling, leading to synergistic actions which have powerful effects. Paracrine and hormonal agents which exert predominant vasoconstrictor effects also stimulate reabsorptive processes to enhance recovery of salt and water, while those which exert vasodilator actions reduce reabsorption and oxygen demand.


PLOS ONE | 2013

TRPP2 and TRPV4 Form an EGF-Activated Calcium Permeable Channel at the Apical Membrane of Renal Collecting Duct Cells

Zhi-Ren Zhang; Wen-Feng Chu; Binlin Song; Monika Gooz; Jia-Ning Zhang; Chang-Jiang Yu; Shuai Jiang; Aleksander Baldys; Pal Gooz; Stacy L. Steele; Grzegorz Owsianik; Bernd Nilius; Peter Komlosi; P. Darwin Bell

Objective Regulation of apical calcium entry is important for the function of principal cells of the collecting duct. However, the molecular identity and the regulators of the transporter/channel, which is responsible for apical calcium entry and what factors regulate the calcium conduction remain unclear. Methods and Results We report that endogenous TRPP2 and TRPV4 assemble to form a 23-pS divalent cation-permeable non-selective ion channel at the apical membrane of renal principal cells of the collecting duct. TRPP2\TRPV4 channel complex was identified by patch-clamp, immunofluorescence and co-immunprecipitation studies in both principal cells that either possess normal cilia (cilia (+)) or in which cilia are absent (cilia (-)). This channel has distinct biophysical and pharmacological and regulatory profiles compared to either TRPP2 or TRPV4 channels. The rate of occurrence detected by patch clamp was higher in cilia (-) compared to cilia (+) cells. In addition, shRNA knockdown of TRPP2 increased the prevalence of TRPV4 channel activity while knockdown of TRPV4 resulted in TRPP2 activity and knockdown of both proteins vastly decreased the 23-pS channel activity. Epidermal growth factor (EGF) stimulated TRPP2\TRPV4 channel through the EGF receptor (EGFR) tyrosine kinase-dependent signaling. With loss of cilia, apical EGF treatment resulted in 64-fold increase in channel activity in cilia (-) but not cilia (+) cells. In addition EGF increased cell proliferation in cilia (-) cell that was dependent upon TRPP2\TRPV4 channel mediated increase in intracellular calcium. Conclusion We conclude that in the absence of cilia, an EGF activated TRPP2\TRPV4 channel may play an important role in increased cell proliferation and cystogenesis.


American Journal of Physiology-renal Physiology | 2014

Evidence for pericyte origin of TSC-associated renal angiomyolipomas and implications for angiotensin receptor inhibition therapy

Brian J. Siroky; Hong Yin; Bradley P. Dixon; Ryan J Reichert; Anna R. Hellmann; Thiruvamoor Ramkumar; Zenta Tsuchihashi; Marlene A. Bunni; Joshua Dillon; P. Darwin Bell; Julian Roy Sampson; John J. Bissler

Nearly all patients with tuberous sclerosis complex (TSC) develop renal angiomyolipomas, although the tumor cell of origin is unknown. We observed decreased renal angiomyolipoma development in patients with TSC2- polycystic kidney disease 1 deletion syndrome and hypertension that were treated from an early age with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers compared with patients who did not receive this therapy. TSC-associated renal angiomyolipomas expressed ANG II type 1 receptors, platelet-derived growth factor receptor-β, desmin, α-smooth muscle actin, and VEGF receptor 2 but did not express the adipocyte marker S100 or the endothelial marker CD31. Sera of TSC patients exhibited increased vascular mural cell-secreted peptides, such as VEGF-A, VEGF-D, soluble VEGF receptor 2, and collagen type IV. These findings suggest that angiomyolipomas may arise from renal pericytes. ANG II treatment of angiomyolipoma cells in vitro resulted in an exaggerated intracellular Ca(2+) response and increased proliferation, which were blocked by the ANG II type 2 receptor antagonist valsartan. Blockade of ANG II signaling may have preventative therapeutic potential for angiomyolipomas.


American Journal of Physiology-lung Cellular and Molecular Physiology | 2014

Deletion of airway cilia results in noninflammatory bronchiectasis and hyperreactive airways

Sandra K. Gilley; Antine E. Stenbit; Raymond C. Pasek; Kelli M. Sas; Stacy L. Steele; May Y. Amria; Marlene A. Bunni; Kimberly P. Estell; Lisa M. Schwiebert; Patrick A. Flume; Monika Gooz; Courtney J. Haycraft; Bradley K. Yoder; Caroline Miller; Jacqueline A. Pavlik; Grant A. Turner; Joseph H. Sisson; P. Darwin Bell

The mechanisms for the development of bronchiectasis and airway hyperreactivity have not been fully elucidated. Although genetic, acquired diseases and environmental influences may play a role, it is also possible that motile cilia can influence this disease process. We hypothesized that deletion of a key intraflagellar transport molecule, IFT88, in mature mice causes loss of cilia, resulting in airway remodeling. Airway cilia were deleted by knockout of IFT88, and airway remodeling and pulmonary function were evaluated. In IFT88(-) mice there was a substantial loss of airway cilia on respiratory epithelium. Three months after the deletion of cilia, there was clear evidence for bronchial remodeling that was not associated with inflammation or apparent defects in mucus clearance. There was evidence for airway epithelial cell hypertrophy and hyperplasia. IFT88(-) mice exhibited increased airway reactivity to a methacholine challenge and decreased ciliary beat frequency in the few remaining cells that possessed cilia. With deletion of respiratory cilia there was a marked increase in the number of club cells as seen by scanning electron microscopy. We suggest that airway remodeling may be exacerbated by the presence of club cells, since these cells are involved in airway repair. Club cells may be prevented from differentiating into respiratory epithelial cells because of a lack of IFT88 protein that is necessary to form a single nonmotile cilium. This monocilium is a prerequisite for these progenitor cells to transition into respiratory epithelial cells. In conclusion, motile cilia may play an important role in controlling airway structure and function.

Collaboration


Dive into the P. Darwin Bell's collaboration.

Top Co-Authors

Avatar

Kelli M. Sas

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

Marlene A. Bunni

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

Stacy L. Steele

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

May Y. Amria

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

Antine E. Stenbit

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Brian J. Siroky

Cincinnati Children's Hospital Medical Center

View shared research outputs
Top Co-Authors

Avatar

Courtney J. Haycraft

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

John J. Bissler

University of Tennessee Health Science Center

View shared research outputs
Top Co-Authors

Avatar

Michael G. Janech

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

Monika Gooz

Medical University of South Carolina

View shared research outputs
Researchain Logo
Decentralizing Knowledge